Iceland· IS-EU/1/13/823/002 & 004
Adasuve
A loxapine product containing loxapinum inn, registered in Iceland by Ferrer Internacional S.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Loxapine is registered in 12 of 19 countries.
Countries holding a registration under ATC N05AH01 (loxapine), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Loxapine · ATC N05AH01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of loxapine costs, country by country.
Normalised to the WHO defined daily dose (9.1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Loxapine · price per daily dose (9.1 mg)
USD · FX 28 Sept 2026
- FR France$0.043
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Loxapinum INN
- Manufacturer
- Ferrer Internacional S.A.
- Country
- Iceland (IS)
- ATC code
- N05AH01
- ATC class
- Loxapine
- Defined daily dose
- 9.1 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
122 interactions on record for loxapine.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Loxapine · interactions on record
122 records
- 12 severe
- 97 moderate
- 1 minor
- 12 info
Most severe, free to view
- MetoclopramideA03FA01severe
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Loxapine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADASUVEFerrer Internacional, S.A., Barcelona
- SpainADASUVE 9,1 MG POLVO PARA INHALACION (UNIDOSIS)Ferrer Internacional S.A.
- United KingdomAdasuve 9.1mg/dose inhalation powderGalen Ltd
- IrelandADASUVE 9.1 mg inhalation powder, pre-dispensedFerrer Internacional, S.A
- NetherlandsAdasuve 9,1 mg inhalatiepoeder, voorverdeeldFerrer Internacional S.A.
- PolandAdasuveFerrer Internacional, S.A.
- BelgiumAdasuve 9.1 mgAlexza UK
- SwedenADASUVE 9,1 mg Inhalationspulver, avdelad dosFerrer Internacional, SA.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- France · Loxapac, Loxapine Arrow
- Liechtenstein · Adasuve
- Norway · Adasuve
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/430e466d-1386-456d-9cd0-43ddf040bfbb GET /v1/drugs/430e466d-1386-456d-9cd0-43ddf040bfbb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innöndunarduft, afmældir skammtar",
"source": "lyfjastofnun",
"atc_raw": "N05AH01",
"marketed": false,
"strength": "9,1 mg",
"ma_number": "EU/1/13/823/002 & 004",
"substance": "Loxapinum INN",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "41325"
}See everything about loxapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.